A novel therapeutic approach for an existing drug reverses a condition in elderly patients who are at high risk for dementia due to Alzheimer’s disease, researchers at Johns Hopkins University found
The drug, commonly used to treat epilepsy, calms hyperactivity in the brain of patients with amnestic mild cognitive impairment (aMCI), a clinically recognized condition in which memory impairment is greater than expected for a person’s age and which greatly increases risk for Alzheimer’s dementia, according to the study published this week in NeuroImage: Clinical.
The findings validate the Johns Hopkins team’s initial conclusions, published three years ago in the journal Neuron. They also closely match the results in animal studies performed by the team and scientists elsewhere. Next, neuroscientist Michela Gallagher, the lead investigator, hopes the therapy will be tested in a large-scale, longer-term clinical trial.
Hippocampal over-activity is well-documented in patients with aMCI and its occurrence predicts further cognitive decline and progression to Alzheimer’s dementia, Gallagher said.
“What we’ve shown is that very low doses of the atypical antiepileptic levetiracetam reduces this over-activity,” Gallagher said. “At the same time, it improves memory performance on a task that depends on the hippocampus.”
The team studied 84 subjects — 17 of them were normal healthy aged participants and the rest had the symptoms of pre-dementia memory loss defined as aMCI. Everyone was over 55 years old, with an average age of about 70.
The subjects were given varying doses of the drug and also a placebo in a double-blind randomized trial. Researchers found low doses both improved memory performance and normalized the over-activity detected by functional magnetic resonance imaging that measures brain activity during a memory task. The ideal dosing found in this clinical study matched earlier preclinical studies in animal models.
“What we want to discover now, is whether treatment over a longer time will prevent further cognitive decline and delay or stop progression to Alzheimer’s dementia,” Gallagher said.
Read more: Drug Restores Brain Function and Memory in Early Alzheimer’s Disease
The Latest on: Alzheimer’s Disease
[google_news title=”” keyword=”Alzheimer’s Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s Disease
- This Morning viewers in tears as The Piano star opens up about dementiaon April 30, 2024 at 3:46 am
A talented contestant on Channel 4's The Piano and his wife have opened up on what music means to their love story and his battle with dementia.
- Does obesity really increase your risk of dementia?on April 30, 2024 at 2:18 am
We also know that obesity damages the tiny vessels supplying blood to the brain, and is a major cause of high blood pressure, diabetes and chronic inflammation, all of which have been repeatedly ...
- Annovis Bio: Searching For Efficacy In Alzheimer's Diseaseon April 30, 2024 at 1:49 am
Annovis Bio announced their phase 2/3 Alzheimer's Disease trial results, causing the stock to drop significantly. Check out my thoughts on the results.
- My father's last lesson: What I learned as my dad grappled with Alzheimer'son April 30, 2024 at 1:08 am
I felt helpless witnessing my dad’s devolution from happy warrior to hapless prisoner. Still, I was able to learn from my father's Alzheimer's.
- Walk to End Alzheimer's, South Orange Countyon April 30, 2024 at 12:44 am
The Walk to End Alzheimer's(r) is the world's largest fundraiser for Alzheimer's care, support and research. This inspiring event calls on participants of all ages and abilities to join the ...
- Researchers discover the mechanism that links a diet rich in fats with Alzheimer's diseaseon April 29, 2024 at 2:26 pm
A study led by the Universitat Rovira i Virgili (URV) has revealed the mechanism behind the link between a diet high in saturated fats and Alzheimer's disease. The research focused on how this kind of ...
- What Maria Shriver Wants Women to Know About Reducing Alzheimer's Disease Riskon April 29, 2024 at 7:21 am
Maria Shriver is taking on Alzheimer's disease and specifically wants women to know they are at higher risk for the condition. She has founded the Women’s Alzheimer’s Movement at Cleveland Clinic, the ...
- What Is the Difference Between Dementia and Alzheimer’s?on April 25, 2024 at 5:00 pm
Alzheimer’s disease and other types of dementia all affect memory, behavior, and communication. But dementia is a general term for these symptoms, while Alzheimer’s is the most common type of ...
- The number of people with Alzheimer’s disease in their 40s or 50s could be underestimatedon April 24, 2024 at 8:33 am
Could you develop this disease at such an early age? Your family history could be telling, medical professionals say.
- Gut Microbiome Linked to Alzheimer's Disease, Scientists Sayon April 23, 2024 at 3:23 am
The findings could lead to the development of new therapeutic interventions or drugs to prevent Alzheimer's disease.
via Bing News